Greg D. Aunan - 01 May 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Chief Accounting Officer
Signature: /s/ Ali Olivo, Attorney-in-Fact
Issuer symbol: NEO
Transactions as of: 01 May 2024
Net transactions value: $0
Form type: 4
Filing time: 03 May 2024, 16:07:59 UTC
Previous filing: 24 May 2023
Next filing: 25 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Tax liability	$0	-937	-6.1%	$0.000000	14,453	01 May 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEO	Stock Option (Right to Buy)	Award	$0	+26,978		$0.000000	26,978	02 May 2024	Common Stock	26,978	$13.96	Direct	F3
transaction	NEO	Restricted Stock Unit	Award	$0	+16,117		$0.000000	16,117	02 May 2024	Common Stock	16,117	$0.000000	Direct	F4, F5
holding	NEO	Stock Option (Right to Buy)						28,662	01 May 2024	Common Stock	28,662	$14.62	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the May 1, 2024 vesting of restricted stock.
F2	On May 1, 2023, Mr. Aunan was granted 28,662 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3	On May 2, 2024, Mr. Aunan was granted 26,978 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4	On May 2, 2024, Mr. Aunan was granted 16,117 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F5	Once vested, the shares of common stock are not subject to expiration.